Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell membrane and cell envelope components represent a critical set of structures that maintain the physical integrity and physiological function of bacteria. In Gram-positive bacteria, the envelope consists of a thick peptidoglycan layer and a cytoplasmic membrane, while Gram-negative bacteria possess a thinner peptidoglycan layer and an additional outer membrane containing lipopolysaccharides (Silhavy et al., 2010). These structures serve as the primary barrier against environmental stress and osmotic pressure, while also facilitating nutrient transport and signal transduction (Cabeen & Jacobs-Wagner, 2005). Because these components are often unique to prokaryotes, they are highly effective targets for antimicrobial therapy. Drugs like beta-lactams and glycopeptides inhibit the synthesis of the peptidoglycan cell wall, leading to osmotic lysis (Kohanski et al., 2010). Other agents, such as polymyxins and lipopeptides, directly disrupt the lipid bilayer or outer membrane, causing leakage of intracellular contents and rapid cell death (Straus & Hancock, 2006). Understanding these components is essential for addressing antimicrobial resistance, as many bacteria modify their envelope structures to evade drug action (Munita & Arias, 2016). This target class remains a cornerstone of infectious disease management despite the emergence of resistant strains.
Inhibition of peptidoglycan synthesis by targeting penicillin-binding proteins or lipid carriers, and direct disruption of membrane integrity or potential.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane and cell envelope components.